These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25822863)

  • 1. Hepatogastroenterologists' knowledge of inactive carriers and immunotolerant hepatitis B virus patients in France: results of a practice survey.
    Causse X; Cadranel JF; Potier P; Hanslik B; Denis J; Renou C; Delasalle P; ;
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):544-9. PubMed ID: 25822863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus.
    Yim SY; Um SH; Jung JY; Seo YS; Yim HJ; Ryu HS; Chun HJ; Jeen YT; Kim CD; Keum B; Lee HS
    J Clin Gastroenterol; 2014 Feb; 48(2):166-71. PubMed ID: 24045280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome.
    Andreani T; Serfaty L; Mohand D; Dernaika S; Wendum D; Chazouillères O; Poupon R
    Clin Gastroenterol Hepatol; 2007 May; 5(5):636-41. PubMed ID: 17428739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
    Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
    J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.
    Chu CM; Chen YC; Tai DI; Liaw YF
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):535-40. PubMed ID: 20304099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nationwide large survey on hepatitis B surface antigen quantification use in real-life clinical practice.
    Halfon P; Penaranda G; Mohamed S; Camus C; Khiri H
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):557-60. PubMed ID: 25822864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and serological assessment of chronic HBV carriers and additional burden of applying updated guidelines in Pakistan.
    Hussain AB; Ahmed SA; Khan FA; Ghani E; Rathore MA; Ali N
    J Coll Physicians Surg Pak; 2014 Sep; 24(9):620-3. PubMed ID: 25233962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of hepatitis B surface antigen in a real-life clinical cohort of patients with chronic hepatitis B virus infection.
    Habersetzer F; Moenne-Loccoz R; Meyer N; Schvoerer E; Simo-Noumbissie P; Dritsas S; Baumert TF; Doffoël M
    Liver Int; 2015 Jan; 35(1):130-9. PubMed ID: 25145784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
    Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K
    J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
    Akhan SC; Yulugkural Z; Vahaboglu H
    Chemotherapy; 2007; 53(6):402-6. PubMed ID: 17934260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum hepatitis B surface antigen kinetics in severe reactivation of hepatitis B e antigen negative chronic hepatitis B patients receiving nucleoside/nucleotide analogues.
    Wong GL; Chan HL; Lo AO; Chan HY; Tse CH; Chim AM; Wong VW
    Antivir Ther; 2013; 18(8):979-86. PubMed ID: 23744529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing serum levels of quantitative hepatitis B surface antigen and hepatitis B virus DNA in hepatitis B virus surface antigen carriers: a follow-up study of an elderly cohort.
    Kuo YH; Chang KC; Wang JH; Tsai PS; Hung SF; Hung CH; Lu SN
    Kaohsiung J Med Sci; 2015 Feb; 31(2):102-7. PubMed ID: 25645989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term follow-up of a large cohort of inactive HBsAg (+)/ HBeAg (-)/ anti-HBe (+) carriers in Greece.
    Gigi E; Lalla T; Orphanou E; Sinakos E; Vrettou E; Raptopoulou-Gigi M
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):19-22. PubMed ID: 17410284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.
    Chan HL; Chan CK; Hui AJ; Chan S; Poordad F; Chang TT; Mathurin P; Flaherty JF; Lin L; Corsa A; Gaggar A; Subramanian GM; McHutchison JG; Lau G; Lee S; Gane EJ
    Gastroenterology; 2014 May; 146(5):1240-8. PubMed ID: 24462735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.
    Yalçin K; Değertekin H; Alp MN; Tekeş S; Satici O; Budak T
    Turk J Gastroenterol; 2003 Sep; 14(3):157-63. PubMed ID: 14655057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between serum quantitative HBsAg, ALT and HBV DNA levels in HBeAg negative chronic HBV infection.
    Günal Ö; Barut Ş; Etikan İ; Duygu F; Tuncel U; Sünbül M
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():142-6. PubMed ID: 25910293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
    Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD
    Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.